Research
20 Years in the Making
Since 2004: Research Documenting the Benefits of Our Ingredients and Their Ability to Improve Outcomes for Those With ASD.**
We invite you to explore the research, examine the clinical evidence, and explore how Cerecell might provide nutritional support for your child.
Dosing Guides
Create a printable “Personalized Dosing Guide” for you or your child using the link below.
View/Download Dosing Guide:
AC1 Enhanced Nutritional Supplementation Powder Dosing Guide
View/Download Dosing Guide:
AC1 Enhanced Nutritional Supplementation Powder Dosing Guide
AC2 Enhanced Nutritional Supplementation Capsules Dosing Guide
View/Download Dosing Guide:
AC2 Enhanced Nutritional Supplementation Capsules Dosing Guide
** These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, cure or prevent any disease.
Cerecell is to be used only as an adjunctive supplement. It is not to be used as a replacement or alternative to FDA-approved treatments for ASD, CPAE, PANDAS, or PANS. Please consult with your pediatrician or primary care provider to determine whether this supplement is a good fit for your child.
Note: The information presented on this site is for educational purposes only and is not intended to replace advice from your physician or other health care professional or any information found on any product label or packaging. You should always consult with a qualified health care professional before starting any exercise, diet or supplement regimen.
Cerecell recommends that FDA-approved treatments for autism, including Occupational Therapy, Feeding Therapy, Speech Therapy, ABA, Music Therapy, and any other FDA-approved modalities implemented by the patient’s provider, should be used as the first line of treatment.
For CPAE, PANDAS, and PANS, Cerecell endorses all standard FDA therapies as directed by the University of Arizona CPAE clinic, under the Steele Center, considering them the Gold Standard for treating children with these conditions.
Dr. Spiekerman, of Arcadia Pediatric Consulting, is an owner of Cerecell, a division of Arcadia Therapeutics Corp., and stands to gain financially from its sale.